Related Experiment Video
Updated: Mar 6, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Gastroprotective Effect of Thymoquinone on Water Immersion Restraint Stress Induced Ulceration in Rats
Syed Sufiyan Ahmad1, Abul Kalam Najmi1, Madhu Kaundal1
1Department of Pharmacology, Faculty of Pharmacy, Jamia Hamdard, (Hamdard University), Hamdard Nagar, New Delhi, India.
Abstract:
To evaluated the role of thymoquinone (TQ) on stress induced ulceration progress in rats subjected to water immersion restraint as a stress (WRS) condition model. Wistar albino rats were divided into different groups; the animals were subjected to WRS. TQ (10 mg/kg) alone and TQ with ranitidine (20 mg/kg) were administered per orally as pre treatment for 7 days. On 8th day the animals were sacrificed, gastric juice, pH, acid secretion, acid output, ulcer index and markers of oxidative stress and histopathology were determined. Volume of gastric juice, acid secretion was increased, while pH decreased in WRS animals. TQ pre-treated group showed reduction in the above parameters. The combination group showed more significant results than TQ and ranitidine alone on the above parameters. TQ decreased the ulcer index (UI), again combination group showed more significant decreased in UI. Oxidative stress markers were reduced and antioxidant enzymes were augmented. Gastric mucosa was protected as demonstrated by histological slides. The present study is one of its kinds to demonstrate anti ulcer effect of TQ against the water immersion restraint method of stress ulceration. Thus, TQ has the potential to be the promising drug for stress induced gastric ulcers.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

